Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
Clinical trial NCT01909934 · COMPLETED
Trial details
- NCT number
- NCT01909934
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-23
- Primary completion
- 2021-05-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.